Cg Oncology Inc.
CGON
Get informed when a big investor buys or sells
+ FollowMarket Cap$5.49B
Close$
$-3.59
106.6% downside
Current Fair Value
106.6% downsideOvervalued by 106.6% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $5.49 Billion |
|---|---|
| Enterprise Value | $5.47 Billion |
| Dividend Yield | $- (-) |
| Earnings per Share | $-2.08 |
| Beta | 0.42 |
| Outstanding Shares | 84,518,512 |
Return
| Return on Equity | -3.78% |
|---|---|
| Return on Assets | -3.64% |
| Return on Invested Capital | -18.87% |
Valuation & Multiples
| P/E Ratio | -28.19 |
|---|---|
| PEG | 28.19 |
| Price to Sales | - |
| Price to Book Ratio | 4.54 |
| Enterprise Value to Revenue | 1078.29 |
| Enterprise Value to EBIT | -26.34 |
| Enterprise Value to Net Income | -133 |
| Total Debt to Enterprise | 0 |
| Debt to Equity | 0.01 |
Revenue Sources
No data
Insider Trades
Last Earnings Call
Report Date
May 12, 2026
EPS Estimate
$-0.58
Average shareholder expectationRevenue Estimate
-
Average shareholder expectationNext Earnings Call
Expected Date
August 7, 2026
EPS Estimate
$-0.70
Average shareholder expectationRevenue Estimate
$333,051
Average shareholder expectationInstitutional Put/Call Ratio
Market sentiment based on institutional option activity.
| Put/Call Ratio | 0.4395▲ 2.63% |
|---|---|
| Total Calls | 2,921,200▲ 71.17% |
| Total Puts | 1,284,000▲ 82.08% |
Institutional Ownership
Holdings and activity of institutional investors.
| Ownership % | 114.01%▲ 6.31% |
|---|---|
| Total Invested | $5.93B▲ 72.82% |
| Investors Holding | 246▲ 41.00% |
ESG Score
No data